Baldwin calls on drug companies to stop gaming patents for asthma inhalers
Sen. Tammy Baldwin (D-Wis.) is calling on four major inhaler manufacturers to stop inappropriately listing their patents in the Food and Drug Administration’s (FDA) database. This action could delay the introduction of low-cost generic drugs to the market. In a letter sent Monday to AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline (GSK) and Teva, Mr. Baldwin said that […]
Asthma drug Singulair linked to negative mental side effects
The Food and Drug Administration (FDA) issued a warning against commonly prescribed asthma medications in 2020, but millions of people are still taking them. A black box warning (also known as a box warning) Published by FDA in March 2020 Regarding the mental health side effects of Singulair, also known by its generic name, montelukast […]